← Back
$TEVA All transactions

TEVA PHARMACEUTICAL INDUSTRIES LTD

A

$ Value

$0

Shares

141,478

Price

$0

Filed

Jan 29

Insider

Name

Sabag Mark

Title

See "Remarks"

CIK

0001721442

Roles

Officer

Transaction Details

Transaction Date

2026-01-27

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

141,478

Footnotes

Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. | Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 3, 2026. | The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Filing Info

Accession No.

0001193125-26-029312

Form Type

4

Issuer CIK

0000818686

Sabag Mark's History

Date Ticker Type Value
2026-01-27 TEVA A $0
2025-12-09 TEVA M $2.2M
2025-12-09 TEVA $3.4M
2025-12-09 TEVA $2.8M
2025-12-09 TEVA M $0
2025-05-08 TEVA $6.1M

Other Insiders at TEVA (90d)

Insider Bought Sold Last
Francis Richard D
President and CEO
$15.3M 2026-02-15
Daniell Richard
Exec. VP, European Commercial
2026-01-27
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
$11.6M 2026-02-26
Hughes Eric A
See "Remarks"
2026-01-27